Streetbeat News

Stock Prices

ELF

e.l.f. Beauty (NYSE:ELF) has received mostly bullish ratings from analysts in the last quarter, with 4 bullish, 6 somewhat bullish, and 2 indifferent ratings. The average 12-month price target for the company is $113.67, which has increased by 10.71% over the past month.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 1:01 pm

PYPL

Over the past 3 months, 27 analysts have published their opinion on PayPal Holdings (NASDAQ:PYPL) stock. The company has an average price target of $87.48, a decrease of 7.43% from the previous average price target of $94.50. The analysts' ratings range from bullish to indifferent, with no bearish ratings.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 1:01 pm

BLK

BlackRock's (NYSE:BLK) short percent of float has fallen 12.68% since its last report, indicating a more bullish sentiment towards the stock. The company has 1.84 million shares sold short, which is 1.24% of all regular shares available for trading. Compared to its peers, BlackRock has less short interest as a percentage of float, with an average of 3.16%.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 1:00 pm

HBAN

Huntington Bancshares (NASDAQ:HBAN) has received various analyst ratings in the last quarter, with 3 bullish, 2 somewhat bullish, and 1 indifferent. The average 12-month price target for the company is $13.0, a decrease of 1.89% from the previous average of $13.25.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 1:00 pm

CI

Cigna Group's (NYSE:CI) short percent of float has risen 7.77% since its last report, with 3.28 million shares sold short, which is 1.11% of all regular shares available for trading. It would take traders 2.12 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. Cigna Group's peer group average for short interest as a percentage of float is 8.17%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 1:00 pm

KOSS

Koss Corporation's shares are experiencing a surge in trading volume due to heightened interest from retail investors.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 1:00 pm

OB

Over the past 3 months, 8 analysts have published their opinion on Outbrain (NASDAQ:OB) stock. The average price target is $5.88, implying an upside from the current price of $5.17. This average has decreased by 12.89% from the previous average price target of $6.75.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 1:00 pm

COP

ConocoPhillips's (NYSE:COP) short percent of float has fallen 12.2% since its last report, with 8.72 million shares sold short, which is 0.72% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards the stock. Compared to its peers, ConocoPhillips has less short interest as a percentage of float, with an average of 6.26%.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 1:00 pm

USB

Analysts have provided various ratings for U.S. Bancorp (NYSE:USB) within the last quarter, with 2 bullish, 2 somewhat bullish, and 8 indifferent. The average price target is $41.33, implying an upside from the current price of $38.42. This average has increased by 9.08% from the previous average price target of $37.89.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 1:00 pm

HZNP

Horizon Therapeutics' Phase 2 trial for daxdilimab, a candidate for treating Systemic Lupus Erythematosus (SLE), failed to meet its primary endpoint. The study did not show a significant difference between daxdilimab and placebo in terms of patient response and oral glucocorticoid dose reduction. No safety concerns were reported. Horizon's shares are down 0.42% premarket.

Portfolio Pulse from Vandana Singh

July 24, 2023 | 1:00 pm